Both oral and poster presentations focused on our recent novel findings about a connection between polycystic ovaries (PCO) and specific angiogenic growth factors that may be responsible for the increased risk of ovarian hyperstimulation syndrome (OHSS) that occurs when women with PCO receive fertility medications. These novel findings may one day help us learn how to reduce the risk of ovarian hyperstimulation, a well known complication of women who have PCO when undergoing fertility treatments. Authors of the studies included: Reshef Tal MD PhD, David Seifer MD, Aya Shohat-Tal PhD, Richard Grazi MD and Henry Malter PhD.
More from Fertility Health
How the GENESIS process assures the accuracy of our patient specimens
In Vitro Fertilization (IVF) and Intrauterine Insemination (IUI) are well-established, safe and effective treatment options for infertility. But sometimes patients…
Read More
How the GENESIS process assures the accuracy of our patient specimens
Read More
Cultural Perspectives on Fertility and Assisted Reproductive Technologies
Navigating the diverse terrain of cultural perspectives on fertility reveals a fascinating collection of beliefs and practices that shape how…
Read More
Cultural Perspectives on Fertility and Assisted Reproductive Technologies
Read More
What to know about insurance and infertility
If you are planning to seek infertility treatment, you are no doubt concerned about affording treatment. Many couples handle the…
Read More
What to know about insurance and infertility
Read More